Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Cascione, Luciano ^a,b   Gasparini, Pierluigi ^a   Lovat, Francesca ^a   Carasi, Stefania ^a   Pulvirenti, Alfredo ^b   Ferro, Alfredo ^b   Alder, Hansjuerg ^a   He, Gang ^a   Vecchione, Andrea ^a,c   Croce, Carlo M ^a   Shapiro, Charles L ^d   Huebner, Kay ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b UNIVERSITY OF CATANIA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL9 CHEMOKINE; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MESSENGER RNA; MICRORNA; MICRORNA 101; MICRORNA 125B; MICRORNA 126; MICRORNA 145; MICRORNA 155; MICRORNA 16; MICRORNA 21; MICRORNA 27A; MICRORNA 374A; MICRORNA 421; MICRORNA 424; MICRORNA 497; MICRORNA 579; MICRORNA 627; MICRORNA 655; MICRORNA 9; MICRORNA LET 7G; MYC PROTEIN; PROTEIN BCL 2; SCATTER FACTOR RECEPTOR; STAT1 PROTEIN; STROMELYSIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER SURVIVAL; CCND1 GENE; COMPUTER MODEL; CONTROLLED STUDY; CXCL9 GENE; DISEASE FREE INTERVAL; DISTANT DISEASE FREE INTERVAL; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC REGULATION; HUMAN; HUMAN TISSUE; IL8 GENE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MET GENE; MMP1 GENE; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE MYC; OVERALL SURVIVAL; PHENOTYPIC VARIATION; PREDICTIVE VALUE; PROTO ONCOGENE; SIGNAL TRANSDUCTION; STAT1 GENE; SURVIVAL RATE; TISSUE SPECIFICITY; TRIPLE NEGATIVE BREAST CANCER; UPREGULATION; VALIDATION PROCESS;

ADULT; BREAST; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LYMPHATIC METASTASIS; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84873551499     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055910     Document Type: Article

References (50)

1. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, et al. (2008) The impact of microRNAs on protein output. Nature 455: 64-71.
2. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
3. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, et al. (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137: 1032-1046.
4. Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, et al. (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 121: 2750-2767.
5. O'Day E, Lal A, (2010) MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 12: 201.
6. Janssen EA, Slewa A, Gudlaugsson E, Jonsdottir K, Skaland I, et al. (2010) Biologic profiling of lymph node negative breast cancers by means of microRNA expression. Mod Pathol 23: 1567-1576.
7. Volinia S, Galasso M, Sana ME, Wise TF, Palatini J, et al. (2012) Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc Natl Acad Sci USA 109: 3024-3029.
8. Howe EN, Cochrane DR, Richer JK, (2012) The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity. J Mammary Gland Biol Neoplasia 17: 65-77.
9. Iliopoulos D, Hirsch HA, Struhl K, (2009) An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139: 693-706.
10. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, et al. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-52.
11. Sachdeva M, Mo YY, (2010) miR-145-mediated suppression of cell growth, invasion and metastasis. Am J Transl Res 2: 170-80.
12. Wu H, Zhu S, Mo YY, (2009) Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res 19: 439-48.
13. Qi L, Bart J, Tan LP, Platteel I, Sluis T, et al. (2009) Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma. BMC Cancer 9: 163.
14. Kwak HJ, Kim YJ, Chun KR, Woo YM, Park SJ, et al. (2011) Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 30: 2433-2442.
15. Di Leva G, Briskin D, Croce CM, (2012) MicroRNA in cancer: new hopes for antineoplastic chemotherapy. Ups J Med Sci 117: 202-16.
16. Wang L, Wang J, (2011) MicroRNA-mediated breast cancer metastasis: from primary site to distant organs. Oncogene 31: 2499-2511.
17. Gravgaard KH, Lyng MB, Laenkholm AV, Søkilde R, Nielsen BS, et al. (2012) The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer. Breast Cancer Res Treat 134: 207-217.
18. Yoon S, Choi YC, Lee S, Jeong Y, Yoon J, et al. (2010) Induction of growth arrest by miR-542-3p that targets survivin. FEBS Lett 584: 4048-4052.
19. Garimella SV, Rocca A, Lipkowitz S, (2012) WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis. Mol Cancer Res 10: 75-85.
20. Fang F, Newport JW, (1991) Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes. Cell 66: 731-742.
21. Konecny GE, Pauletti G, Untch M, Wang HJ, Möbus V, et al. (2010) Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer. Breast Cancer Res Treat 120: 481-489.
22. Trojanec R, Koudelakova V, Bouchalova K, Radova L, Ondryasova H, et al. (2011) Role of CCND1 and C-MYC oncogenes in metastatic breast cancer patients treated by herceptin. Breast Cancer Res 13: P9 Available: http://breast-cancer-research.com/supplements/13/S2. Published online 2011 November 16.
23. Mendoza M, Khanna C, (2009) Revisiting the seed and soil in cancer metastasis. Int J Biochem Cell Biol 41: 1452-62.
24. Psaila B, Lyden D, (2001) The metastatic niche: adapting the foreign soil. Nat Rev Cancer 9: 285-93.
25. Xie K, (2001) Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 12: 375-91.
26. Singh B, Berry JA, Vincent LE, Lucci A, (2006) Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer. J Surg Res 134: 44-51.
27. Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, et al. (2007) The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 13: 2329-2334.
28. Martin M, Romero A, Cheang MC, López García-Asenjo JA, García-Saenz JA, et al. (2011) Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer. Breast Cancer Res Treat 128: 127-136.
29. Daves MH, Hilsenbeck SG, Lau CC, Man TK, (2011) Meta-analysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors. BMC Med Genomics 4: 56.
30. Xu J, Li Y, Wang F, Wang X, Cheng B, et al. (2012) Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene Epub ahead of print.
31. Zhang Y, Yan LX, Wu QN, Du ZM, Chen J, et al. (2011) miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res 71: 3552-3562.
32. Zhou M, Liu Z, Zhao Y, Ding Y, Liu H, et al. (2010) MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem 285: 21496-21507.
33. Võsa U, Vooder T, Kolde R, Fischer K, Välk K, et al. (2011) Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer. Genes Chromosomes Cancer 50: 812-822.
34. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
35. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, et al. (2007) MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 8: R214.
36. Kong W, He L, Coppola M, Guo J, Esposito NN, et al. (2010) MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem 285: 17869-17879.
37. McInnes N, Sadlon TJ, Brown CY, Pederson S, Beyer M, et al. (2012) FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells. Oncogene 31: 1045-1054.
38. Li D, Zhao Y, Liu C, Chen X, Qi Y, Jiang Y, et al. (2011) Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res 17: 1722-1730.
39. Hu H, Du L, Nagabayashi G, Seeger RC, Gatti RA, (2010) ATM is down-regulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci USA 107: 1506-1511.
40. Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, et al. (2005) CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50. Mol Cancer Res 3: 585-596.
41. Greenwood C, Metodieva G, Al-Janabi K, Lausen B, Alldridge L, et al. (2011) Stat1 and CD74 overexpression is co-dependent and linked to increased invasion and lymph node metastasis in triple-negative breast cancer. J Proteomics 75: 3031-3040.
42. Nass SJ, Dickson RB, (1997) Defining a role for c-Myc in breast tumorigenesis. Breast Cancer Res Treat 44: 1-22.
43. Snoussi K, Mahfoudh W, Bouaouina N, Fekih M, Khairi H, et al. (2010) Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness. BMC Cancer 10: 283.
44. Knopfová L, Beneš P, Pekarčíková L, Hermanová M, Masařík M, et al. (2012) c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis. Mol Cancer 11: 15.
45. Ramaswamy S, Ross KN, Lander ES, Golub TR, (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54.
46. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, et al. (2008) Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 26: 317-325.
47. Rao Y, Lee Y, Jarjoura D, Ruppert AS, Liu CG, et al. (2008) A comparison of normalization techniques for microRNA microarray data. Stat Appl Genet Mol Biol 7: article 22.
48. Simon R, Lam A, Li MC, Ngan M, Menenzes S, et al. (2007) Analysis of gene expression data using BRB-ArrayTools. Cancer Inform 3: 11-17.
49. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, et al. (2006) TM4 microarray software suite. Methods Enzymol 411: 134-193.
50. Smyth GK (2005) Limma: linear models for microarray data. In Bioinformatics and Computational Biology Solutions using R and Bioconductor. Edited by Gentleman RVC, Dudoit S, Irizarry R, Huber W. New York Springer pp. 397-420.